Sativex + Placebo
Phase 3Completed 1 views this week 0 watching💤 Quiet
Interest: 37/100
37
Development Stage
✓
Pre-clinical✓
Phase 1✓
Phase 24
Phase 35
ApprovedIndication / Disease
Pain
Conditions
Pain, Diabetic Neuropathy
Trial Timeline
Jul 1, 2005 → Jun 1, 2006
NCT ID
NCT00710424About Sativex + Placebo
Sativex + Placebo is a phase 3 stage product being developed by Jazz Pharmaceuticals for Pain. The current trial status is completed. This product is registered under clinical trial identifier NCT00710424. Target conditions include Pain, Diabetic Neuropathy.
What happened to similar drugs?
20 of 20 similar drugs in Pain were approved
Approved (20) Terminated (4) Active (0)
✅Solifenacin succinate treatment + Oxycodone and acetaminophen combination treatmentAstellas PharmaApproved
Hype Score Breakdown
Clinical
17
Activity
8
Company
12
Novelty
0
Community
0
Clinical Trials (7)
| NCT ID | Phase | Status |
|---|---|---|
| NCT01812616 | Phase 1/2 | Completed |
| NCT01898520 | Phase 3 | Completed |
| NCT01964547 | Approved | Completed |
| NCT00702468 | Phase 3 | Completed |
| NCT00710554 | Phase 3 | Completed |
| NCT00710424 | Phase 3 | Completed |
| NCT01599234 | Phase 3 | Completed |
Competing Products
20 competing products in Pain